Regarding tumor formation, although the number of animals used in our studies was low, the striking difference in the incidence of liver neoplasms between animals injected with null vectors or therapeutic vectors actually argues in favor of a protective role of FGF21 against malignancies. The gene discussed is FGF21; the disease is neoplasm.